Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-ISF35 in Non-Hodgkin's Lymphoma
NCT00942409Phase 2Terminated
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Modality
- Gene Editing, Gene Silencing, Adenoviral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of ISF35 in follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL). Started Jun 2009; status: terminated.
02
Drugs
ISF35
03
Conditions
follicular lymphoma (FL)diffuse large B-cell lymphoma (DLBCL)mantle cell lymphoma (MCL)small lymphocytic lymphoma (SLL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00942409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942409.